KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects
Abstract Background Ketamine, a widely used anaesthetic and analgesic agent, is known to improve the analgesic efficacy of opioids and to attenuate central sensitisation and opioid-induced hyperalgesia. Clinical use is, however, curtailed by unwanted psychomimetic effects thought to be mediated by N...
Main Authors: | Martyn Harvey, Jamie Sleigh, Logan Voss, Mike Bickerdike, Ivaylo Dimitrov, William Denny |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40360-019-0374-y |
Similar Items
-
Structure-Activity Relationships for the Anaesthetic and Analgaesic Properties of Aromatic Ring-Substituted Ketamine Esters
by: Ivaylo V. Dimitrov, et al.
Published: (2020-06-01) -
Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
by: Adam Włodarczyk, et al.
Published: (2023-01-01) -
Ketamine as the main analgesic agent during analgesia-based sedation for elective colonoscopy – A randomised, double-blind, control study
by: Mirza Kovačević, et al.
Published: (2022-01-01) -
Non-NMDA Mechanisms of Analgesia in Ketamine Analogs
by: Logan J. Voss, et al.
Published: (2022-02-01) -
Assessment of Analgesic Effect of Ketamine Vs Ketamine Magnesium Infusion and Their Effect on Postoperative Morphine Consumption after Surgical Nephrectomy
by: Nirvana Ahmed Elshalakany
Published: (2023-12-01)